Alan Mart
About Alan Mart
Alan Mart is a Global Regulatory Team Leader with extensive experience in regulatory affairs, currently holding positions at Daiichi Sankyo, Inc. and Bristol-Myers Squibb.
Current Positions at Daiichi Sankyo and Bristol-Myers Squibb
Alan Mart is currently serving dual roles at two prominent pharmaceutical companies. At Daiichi Sankyo, Inc. in Basking Ridge, NJ, he holds the position of Executive Director of Regulatory Affairs. Simultaneously, he is the Global Regulatory Team Leader at Bristol-Myers Squibb in Lawrenceville, NJ. In these capacities, Alan brings his extensive knowledge and leadership skills to manage regulatory teams and strategies effectively.
Past Experience at Roche Pharmaceuticals
Alan Mart worked at Roche Pharmaceuticals as the Global Regulatory Leader from 2003 to 2011. During his eight-year tenure, he contributed significantly to regulatory projects and drug development processes. His role focused on leading global regulatory initiatives and ensuring compliance with international regulatory standards.
Early Career at Schering-Plough and Novartis
Before joining Roche, Alan worked at Schering-Plough HealthCare Products as the Associate Director of Regulatory Affairs from 2000 to 2003. Prior to that, he served for a year at Novartis Consumer Health as the Associate Director of Drug Regulatory Affairs in 1999-2000. These positions allowed him to build his foundational knowledge in regulatory affairs.
Long-standing Tenure at Novartis Pharmaceutical Corp.
Alan's notable career includes a ten-year period at Novartis Pharmaceutical Corp., where he held multiple roles such as Associate Director, Regional Head of Drug Regulatory Affairs, Assistant Director, and Manager of Regulatory Affairs from 1989 to 1999. His long tenure at Novartis highlighted his versatility and deep expertise in regulatory matters.
Educational Background and Expertise
Alan Mart studied Organic Chemistry at Rutgers University, where he achieved his Bachelor's degree. His educational background provided a strong foundation in the sciences, which has underpinned his extensive career in regulatory affairs and drug development.